TOCILIZUMAB - SUBCUTANEOUS INJECTION
PHONETIC PRONUNCIATION: (TOE-si-LIZ-ue-mab)
COMMON BRAND NAME(S): Actemra
GENERIC NAME(S): tocilizumab
Uses
USES: This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis in adults. It is also used to treat a certain type of rheumatoid arthritis in children (polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab is also used to treat giant cell arteritis. It helps to reduce swelling in your blood vessels so blood can flow more easily. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation).
How to use TOCILIZUMAB - SUBCUTANEOUS INJECTION
HOW TO USE: Read the Medication Guide and Instructions for Use provided by your pharmacist before you start using tocilizumab and each time you get a refill. If you have any questions, ask your doctor or pharmacist. If you are using this medication at home, learn all preparation and usage instructions from your health care professional and the product package. Remove one syringe from the refrigerator 30 minutes before using it to allow it to reach room temperature. Do not speed up the warming process in any way; for example, do not use the microwave or place the syringe in warm water. Check this product visually for particles or discoloration. If either is present, do not use the liquid. If you are using this medication to treat rheumatoid arthritis in adults, inject this medication under the skin as directed by your doctor, usually starting with once every 2 weeks, then increasing to once a week. If you are using this medication to treat PJIA in children, give this medication by injection under the skin as directed by the doctor, usually once every 2 or 3 weeks, based on your child's weight. If you are using this medication to treat giant cell arteritis, inject this medication under the skin as directed by your doctor, usually once a week. Recommended injection sites include the abdomen or the front of your thigh. The outer area of the upper arms may also be used if another person is giving you the injection. Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin. Do not inject into moles, scars, bruises, or areas where the skin is tender, red, hard, or broken. Learn how to store and discard medical supplies safely. The dosage is based on your weight, laboratory tests, and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, mark the days you need to inject the medication on a calendar. Tell your doctor if your condition does not improve or if it worsens.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for TOCILIZUMAB - SUBCUTANEOUS INJECTION
Tocilizumab subcutaneous injection is used for the treatment of rheumatoid arthritis, giant cell arteritis, and systemic juvenile idiopathic arthritis.
Tocilizumab subcutaneous injection works by blocking a specific protein called interleukin-6 (IL-6) in the body, which is involved in the inflammation process. By inhibiting IL-6, tocilizumab helps reduce inflammation and alleviate symptoms.
The usual recommended dose for tocilizumab subcutaneous injection is once every two weeks. However, the dosage and frequency may vary depending on your condition and the guidance of your healthcare provider.
Common side effects of tocilizumab subcutaneous injection may include upper respiratory tract infections, headaches, increased blood pressure, and injection site reactions. Serious side effects, although rare, can occur, such as infections, liver problems, and allergic reactions. Inform your doctor if you experience any unusual or severe side effects.
It is important to consult with your healthcare provider before receiving any new medications or vaccines while taking tocilizumab subcutaneous injection. Some medications or vaccines may interact with tocilizumab or affect its effectiveness.
The response to tocilizumab subcutaneous injection may vary for each individual. Some patients may start experiencing relief from symptoms within a few weeks, while for others, it may take several months. It is essential to follow your healthcare provider's instructions and continue the treatment as prescribed to achieve the best results.
Yes, tocilizumab subcutaneous injection can be self-administered at home once you have received appropriate training from your healthcare provider. They will teach you the proper technique to administer the injection safely. However, it is crucial to follow the instructions strictly and seek medical assistance if needed.
If you accidentally miss a dose of tocilizumab subcutaneous injection, it is recommended to take the missed dose as soon as you remember. However, if it is close to the time for your next scheduled dose, it is better to skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Tocilizumab subcutaneous injection is not recommended during pregnancy unless the potential benefits outweigh the potential risks. It is advisable to discuss your pregnancy plans or breastfeeding intentions with your healthcare provider before starting or continuing tocilizumab treatment.
Warning
WARNING: This medication may lower your ability to fight an infection. This may make you more likely to get a serious (rarely fatal) infection or make any infection you have worse. Your risk may be increased if you are also taking other drugs that can lower your ability to fight an infection (such as methotrexate or corticosteroids). Before using tocilizumab, tell your doctor your medical history, especially of any kind of infection. During treatment, tell your doctor right away if you develop any signs of infection (such as cough, sore throat, fever, chills, pain when urinating). Before and during treatment with this medication, your doctor will test you for tuberculosis (TB). Your doctor should also monitor you for symptoms of TB during and after treatment with this drug. If needed, treatment for tuberculosis or other infections should be given before receiving this medication.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet